Jungbunzlauer Tricalcium Citrate Excipient Demonstrates Outstanding Results in Direct Compression Study
- New research confirms Jungbunzlauer's TCC TB supports efficient, high-quality tablet manufacturing…
Cambrex Unveils $120 Million Investment to Expand API Manufacturing and Strengthen U.S. Drug Supply Resilience
EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract…
JOY GROUP Completes Acquisition of Italian Dermatological Hair Care Brand Foltne
SHANGHAI, Oct. 21, 2025 /PRNewswire/ --Â China's leading multi-brand beauty group JOY GROUP…
Virtuosi 2.0 – Unleashed
The Next Generation of BioPharma Education for the Advanced Manufacturing Era ALEXANDRIA,…
Florricks Lifecare Expands Global Footprint with USD 95 Million Investment in Europe and Hong Kong
Florricks Lifecare Private Limited, a leading research-driven global pharmaceutical company renowned for…
Not Just Pharmacy: How Medkart is Building India's Smartest Generic Medicine App
India’s pharmaceutical landscape is undergoing a vital transformation. Despite being home to…
LTS expands its CDMO capabilities with the acquisition of Renaissance Lakewood
ANDERNACH, Germany, Oct. 13, 2025 /PRNewswire/ -- LTS LOHMANN Therapie-Systeme AG ("LTS"),…
MSN Laboratories Launches Affordable JAK Inhibitors to Boost Access for Indian Patients
NEW DELHI, Oct. 9, 2025 /PRNewswire/ -- MSN Laboratories, a leading global…
AscellaHealth Leaders Take the Stage at SIIA National Conference: Present Strategies for Managing High-Cost Claims and Building Pharma Partnerships
BERWYN, Pa., Oct. 07, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner…
Hinge Bio Announces License and Collaboration with Kyorin Pharmaceutical Co., Ltd. for the Development and Commercialization of HB2198 in Japan for Autoimmune Diseases
Hinge Bio to receive $10 million upfront and is eligible to receive…